Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Despite tremendous efforts in the search for safe, efficacious and non-addictive opioids for pain treatment, morphine remains the most valuable painkiller in contemporary medicine. Opioids exert their pharmacological actions through three opioid-receptor classes, mu, delta and kappa, whose genes have been cloned. Genetic approaches are now available to delineate the contribution of each receptor in opioid function in vivo. Here we disrupt the mu-opioid-receptor gene in mice by homologous recombination and find that there are no overt behavioural abnormalities or major compensatory changes within the opioid system in these animals. Investigation of the behavioural effects of morphine reveals that a lack of mu receptors abolishes the analgesic effect of morphine, as well as place-preference activity and physical dependence. We observed no behavioural responses related to delta- or kappa-receptor activation with morphine, although these receptors are present and bind opioid ligands. We conclude that the mu-opioid-receptor gene product is the molecular target of morphine in vivo and that it is a mandatory component of the opioid system for morphine action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, in animal models, dopamine D1 receptor knockout rats will not self-administer cocaine37 and μ opioid receptor knockout mice will not show the rewarding effects of opioids.153”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [153]
In the citing paper
“Mice that lack the MOR gene do not develop place preferences or withdrawal symptoms in response to morphine (Matthes et al 1996).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Matthes et al 1996
Citations
Cites
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationNeutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Roques, B. P., Noble, F., Daugé, V, Fournié-Zaluski, M. C., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 756
Self-citationLufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationChiara, G. D., & Alan North, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90062-b · Cited by 543
Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M., & Nestler, E. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91111-d · Cited by 535
A brief history of opiates, opioid peptides, and opioid receptors.
Brownstein, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5391 · Cited by 491
Multiple opioid receptors: ligand selectivity profiles and binding site signatures.
Goldstein, A., & Naidu, A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09190-4 · Cited by 445
Kieffer, B. L. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071128 · Cited by 389
Self-citationReduction of Morphine Abstinence in Mice with a Mutation in the Gene Encoding CREB
Maldonado, R., Blendy, J. A., Tzavara, E., Gass, P., Roques, B. P., Hanoune, J., & Schütz, G. (1996) · Science · doi:10.1126/science.273.5275.657 · Cited by 292
Self-citationThe mouse Pgk-1 gene promoter contains an upstream activator sequence
McBurney, M. W., Sutherland, L. C., Adra, C. N., Leclair, B., Rudnicki, M. A., & Jardine, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5755 · Cited by 193
Research works printed but not linked: 9
- Goldstein, A. & Naidu, A. Mol. Pharmacol. 36, 265–272 (1989).
- Pasternak, G. W. Clin. Pharmacol. 16, 1–18 (1993).
- Cowan, A. in Handbook of Experimental Pharmacology Opioids II (ed. Herz, A.) Vol. 104, 393–414 (Springer, Berlin, 1993).
- Roques, B. P., Noble, F., Daugé, V., Fournié-Zaluski, M.-C. & Beaumont, A. Pharmacol. Rev. 45, 87–146 (1993).
- Baamonde, A., Daugé, V., Gacel, C. & Roques, B. P. J. Pharmacol. Exp. Ther. 257, 767–773 (1991).
- Koob, G. F. Trends Biochem. Sci. 13, 177–184 (1992).
- Wei, E. T. J. Pharmacol. Exp. Ther. 216, 12–18 (1981).
- Cowan, A., Zhu, X. Z., Mosberg, H. I., Omnaas, J. R. & Porreca, F. J. Pharmacol. Exp. Ther. 246, 950–955 (1988).
- Kitchen, I. et al. J. Pharmacol. Exp. Ther. 275, 1595–1607 (1995).
Cited by
Items 801–900 of 1,002
Mice lacking the G protein γ3-subunit show resistance to opioids and diet induced obesity
Schwindinger, W. F., Borrell, B. M., Waldman, L. C., & Robishaw, J. D. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00308.2009 · Cited by 35
Crist, R. C., Doyle, G. A. R., Nelson, E. C., Degenhardt, L. J., Martin, N. G., Montgomery, G. W., Saxon, A. J., Ling, W. W., & Berrettini, W. H. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.89 · Cited by 31
Ikemoto, M. J., Takita, M., Imamura, T., & Inoue, K. (2000) · Nature Medicine · doi:10.1038/78675 · Cited by 33
μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids
Convertino, M., Samoshkin, A., Gauthier, J., Gold, M. S., Maixner, W. D., Dokholyan, N. V., & Diatchenko, L. B. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.11.009 · Cited by 35
“Several studies have shown that OPRM1 is essential for morphine's analgesic actions because complete OPRM1 KO mice show a complete loss of morphine analgesia (Loh et al., 1998; Matthes et al., 1996; Sora et al., 1997).”
The Role of DNA Methylation in Drug Addiction: Implications for Diagnostic and Therapeutics
Lax, E., & Szyf, M. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.003 · Cited by 28
Analgesia linked to Nav1.7 loss of function requires µ- and δ-opioid receptors
Pereira, V., Millet, Q., Aramburu, J. F., López‐Rodríguez, C., Gavériaux‐Ruff, C., & Wood, J. N. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14687.1 · Cited by 33
Nasseef, M. T., Singh, J. P., Ehrlich, A. T., McNicholas, M., Park, D. W., Ma, W., Kulkarni, P. P., Kieffer, B. L., & Darcq, E. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00021 · Cited by 36
Self-citationSakloth, F., Manouras, L., Avrampou, K., Mitsi, V., Serafini, R. A., Pryce, K. D., Cogliani, V., Berton, O., Jarpe, M. B., & Zachariou, V. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05525-9 · Cited by 30
Mann, A., Liebetrau, S., Klima, M., Dasgupta, P., Massotte, D., & Schulz, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65589-7 · Cited by 35
Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor
Ramos‐Gonzalez, N., Groom, S., Sutcliffe, K. J., Bancroft, S., Bailey, C. P., Sessions, R. B., Henderson, G., & Kelly, E. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16084 · Cited by 30
“The μ opioid receptor is a Gi/o G-protein coupled receptor (GPCR) and agonist activation brings about potent analgesia as well as other effects including respiratory depression and euphoria through downstream signalling initiated largely by activation of G proteins (Matthes et al., 1996).”
BackgroundWelsch, L., Colantonio, E., Frison, M., Johnson, D. A., McClain, S. P., Mathis, V., Banghart, M. R., Hamida, S. B., Darcq, E., & Kieffer, B. L. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.05.019 · Cited by 36
Self-citationThe Challenges of LC–MS/MS Analysis of Opiates and Opioids in Urine
French, D. (2013) · Bioanalysis · doi:10.4155/bio.13.244 · Cited by 29
DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice
Guo, X.-H., Fairbanks, C. A., Stone, L. S., & Loh, H. H. (2003) · Pain · doi:10.1016/s0304-3959(03)00007-1 · Cited by 29
“In a second line of MOR-KO mice, supraspinal administration of both DPDPE and DELT II showed decreased efficacy in MOR-KO compared to wildtype mice (WT, Matthes et al., 1996, exon 2 disruption).”
BackgroundResultSahraei, H., Amiri, Y.-A., Haeri-Rohani, A., Sepehri, H., Salimi, S. H., Pourmotabbed, A., Ghoshooni, H., Zahirodin, A., & Zardooz, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.012 · Cited by 30
Roy, S., Guo, X., Kelschenbach, J., Liu, Y., & Loh, H. H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0332-05.2005 · Cited by 29
“Both analgesia and tolerance to morphine are abolished in -opioid receptor knock-out mice, implicating the -opioid receptor as the primary receptor type mediating both of these effects (Fang et al., 1986; Matthes et al., 1996; Sora et al., 1997).”
BackgroundShoblock, J. R., & Maidment, N. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.011 · Cited by 29
Gene Expression Is Altered in the Lateral Hypothalamus upon Activation of the mu Opioid Receptor
Befort, K., Filliol, D., Darcq, E., Ghate, A., Matifas, A., Lardenois, A., Muller, J., Thibault-Carpentier, C., Dembélé, D., Poch, O., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.028 · Cited by 36
Self-citationMu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons
Walwyn, W. M., Wei, W., Xie, C. W., Chiu, K., Kieffer, B. L., Evans, C. J., & Maidment, N. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.021 · Cited by 29
Self-citationGarcía‐Sevilla, J. A., Ferrer‐Alcón, M., Martín, M., Kieffer, B. L., & Maldonado, R. J. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.006 · Cited by 29
“Opioid dependence was induced by repeated morphine administration (Matthes et al., 1996).”
InfluentialSelf-citationRespiratory function in adult mice lacking the µ‐opioid receptor: role of δ‐receptors
Morin‐Surun, M., Boudinot, É., Dubois, C., Matthes, H. W. D., Kieffer, B. L., Denavit‐Saubié, M., Champagnat, J., & Foutz, A. S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01547.x · Cited by 29
“The development of mice with a disrupted m-opioid receptor gene (Matthes et al., 1996; review in Kieffer, 1999) allows new approaches to this problem.”
BackgroundMethodSelf-citationKarim, F., & Roerig, S. C. (2000) · Pain · doi:10.1016/s0304-3959(00)00279-7 · Cited by 29
“Interestingly, antinociception produced by i.c.v. administration of both mu and delta agonists is blocked or attenuated in the mu receptor de®cient animals (Matthes et al., 1996, 1998; Sora et al., 1997).”
BackgroundIkeda, K., Ichikawa, T., Kobayashi, T., Kumanishi, T., Oike, S., & Yano, R. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00047-4 · Cited by 29
“On the other hand, m-opioid-receptor-deficient (mKO) mice have been recently produced by gene-targeting (Matthes et al., 1996; Sora et al., 1997b; Tian et al., 1997; Loh et al., 1998).”
BackgroundMaximum likelihood resolution of multi-block genotypes
Kimmel, G., & Ron Shamir, A. (2004) · Research in Computational Molecular Biology · doi:10.1145/974614.974616 · Cited by 29
“The SNPs are from the human „ opioid receptor gene (OPRM1) on chromosome 6, which is known to be related to morphine tolerance and dependence [ 16 ].”
BackgroundMoss, L. M., Hijma, H. J., Demitrack, M. A., Kim, J., Groeneveld, G. J., van Velzen, M., Niesters, M., Olofsen, E., & Dahan, A. (2023) · Anesthesiology · doi:10.1097/aln.0000000000004758 · Cited by 28
Impact of chronic morphine on delta opioid receptor-expressing neurons in the mouse hippocampus
Erbs, E., Faget, L. C., Ceredig, R. A., Matifas, A., Vonesch, J., Kieffer, B. L., & Massotte, D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.022 · Cited by 31
“Results Chronic morphine administration induces physical dependence Chronic administration of escalating doses of morphine is a robust treatment that induces drug dependence in mice (Matthes et al., 1996).”
BackgroundSelf-citationDesign and functional evaluation of an optically active μ-opioid receptor
Barish, P. A., Xu, Y., Li, J., Sun, J., Jarajapu, Y. P. R., & Ogle, W. O. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.065 · Cited by 28
Lucerne, K. E., Osman, A., Meckel, K. R., & Kiraly, D. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108598 · Cited by 28
Bailly, J., Allain, F., Schwartz, E., Tirel, C., Dupuy, C., Petit, F., Diana, M. A., Darcq, E., & Kieffer, B. L. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.09.013 · Cited by 34
Self-citationAttenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations
Varani, A. P., Aso, E., Moutinho, L. M., Maldonado, R. J., & Balerio, G. N. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3469-6 · Cited by 28
Self-citationChi, Y., Nakamura, M., Yoshizawa, T., Zhao, X.-Y., Yan, W., Hashimoto, F., Kinjo, J., Nohara, T., & Sakurada, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1989 · Cited by 28
Lu, J. H., Jeon, E. J., Lee, B.-S., Önyüksel, H., & Wang, Z. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.025 · Cited by 29
Han, W., Kasai, S., Hata, H., Takahashi, T., Takamatsu, Y., Yamamoto, H., Uhl, G. R., Sora, I., & Ikeda, K. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000215072.36965.8d · Cited by 32
Pharmacological characterization of AR-M1000390 at human delta opioid receptors
Marie, N., Landemore, G., Debout, C., Jauzac, P., & Allouche, S. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00489-2 · Cited by 28
Liang, J., Li, Y., Ping, X., Yu, P., Zuo, Y., Wu, L., Han, J., & Cui, C. (2006) · Peptides · doi:10.1016/j.peptides.2006.08.011 · Cited by 28
“Moreover, mice lacking the MOR failed to demonstrate morphine-induced CPP [24].”
BackgroundThe Enkephalinergic Osteoblast
Rosen, H., Krichevsky, A., & Bar-Shavit, Z. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.10.1515 · Cited by 28
“These animals show a complete loss of analgesic responses to morphine as well as loss of place-preference activity and physical dependence on this opioid.((23)) Interestingly, lack of a functional receptor resulted in changes in both the host defense system and the reproductive system.”
BackgroundSlowe, S. J., Clarke, S., Léna, I., Goody, R. J., Lattanzi, R., Negri, L., Simonin, F., Matthes, H. W. D., Filliol, D., Kieffer, B. L., et al. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00308-6 · Cited by 39
Self-citationGavériaux‐Ruff, C., Filliol, D., Simonin, F., Matthes, H. W. D., & Kieffer, B. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29492-1 · Cited by 30
Self-citationGerasimov, M. R., Ashby, C. R., Gardner, E. L., Mills, M. J., Brodie, J. D., & Dewey, S. L. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1<11::aid-syn2>3.0.co;2-5 · Cited by 96
Repeated Restraint Stress Reduces Opioid Receptor Binding in Different Rat CNS Structures
Dantas, G., Torres, I. L. D. S., Crema, L. M., Lara, D. R., & Dalmaz, C. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9679-2 · Cited by 34
“In studies using transgenic mice, investigation of the behavioral effects of morphine reveals that a lack of l-receptors abolishes its analgesic effect ( 41 ).”
Sakurada, S., Takeda, S., Sato, T., Hayashi, T., Yuki, M., Kutsuwa, M., Tan–No, K., Sakurada, C., Kisara, K., & Sakurada, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00166-7 · Cited by 28
Tóth, P., Gavériaux‐Ruff, C., & Labourdette, G. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000401)60:1<10::aid-jnr2>3.0.co;2-o · Cited by 27
McPherson, K. B., & Ingram, S. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.963812 · Cited by 31
“Although MORs mediate morphine antinociception (Matthes et al., 1996) all three opioid receptors (MOR, DOR and KOR) are expressed in vlPAG.”
BackgroundDesensitization and Tolerance of Mu Opioid Receptors on Pontine Kölliker-Fuse Neurons
Levitt, E. S., & Williams, J. T. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.109603 · Cited by 27
“The mu opioid receptor is responsible for both the analgesic and respiratory depressant effects caused by morphine (Matthes et al., 1996; Dahan et al., 2001).”
BackgroundPredictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors
Sakamuru, S., Zhao, J., Xia, M., Hong, H., Simeonov, A. M., Vaisman, I. I., & Huang, R. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00439 · Cited by 29
Addiction and the cerebellum with a focus on actions of opioid receptors
Ranjbar, H., Soti, M., Banazadeh, M., Saleki, K., Kohlmeier, K. A., & Shabani, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.021 · Cited by 28
Tramadol induces conditioned place preference in rats: Interactions with morphine and buprenorphine
Zhang, M., Li, J., Liu, Q., Wen, R.-T., Li, J., Li, Y., Gong, Q. H., & Liang, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.037 · Cited by 29
Socially induced morphine pseudosensitization in adolescent mice
Hodgson, S. R., Hofford, R. S., Roberts, K. W., Wellman, P. J., & Eitan, S. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328337be25 · Cited by 27
“, 2009) and those of other investigators (el-Kadi and Sharif, 1994; Spanagel et al., 1994; Matthes et al., 1996; Kest et al., 2001; Contet et al., 2008) who have shown that such doses induce significant antinociceptive tolerance, locomotor sensitization, dependence, and withdrawal.”
BackgroundAssociation study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population
Ding, S., Chen, B., Zheng, Y., Lu, Q., Liu, L., & Zhuge, Q. C. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-107 · Cited by 28
Gago, B., Suárez‐Boomgaard, D., Fuxé, K., Brené, S., Reina‐Sánchez, M. D., Rodríguez‐Pérez, L., Agnati, L. F., de la Calle, A., & Rivera, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.046 · Cited by 31
Zhang, Z., & Pan, Z. Z. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.076307 · Cited by 28
“Both the analgesic and reinforcing effects of opioids are mediated primarily by MOR, which is readily expressed on surface membrane of central neurons (Matthes et al., 1996; Contet et al., 2004; Waldhoer et al., 2004).”
BackgroundGarbugino, L., Centofante, E., & D'Amato, F. R. (2016) · Neural Plasticity · doi:10.1155/2016/5346161 · Cited by 37
“Defective social behaviors are among the symptoms shared by different neuropsychiatric disorders such as depression, schizophrenia, and autism.”
BackgroundCivciristov, S., Huang, C., Liu, B., Marquez, E. A., Gondin, A. B., Schittenhelm, R. B., Ellisdon, A. M., Canals, M., & Halls, M. L. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008685 · Cited by 30
“coupled receptor (GPCR) that mediates the effects of opioid-based analgesics such as morphine (1).”
BackgroundLaw, P., Yang, J. W., Guo, X., & Loh, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334906100 · Cited by 27
Han, W., Ide, S., Sora, I., Yamamoto, H., & Ikeda, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1307.045 · Cited by 27
Ceccarelli, I., Fiorenzani, P., Grasso, G., Lariviere, W. R., Massafra, C., Massai, L., Muscettola, M., & Aloisi, A. M. (2004) · Pain · doi:10.1016/j.pain.2004.06.005 · Cited by 27
“Moreover, mice lacking the mOR show normal behavioural responses to acute noxious thermal stimuli (Matthes et al., 1996).”
BackgroundEscribá, P. V., & Garcı́a-Sevilla, J. A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702555 · Cited by 27
“They are involved in nociceptive processing and morphine-induced analgesia, as well as in the development and expression of morphine addiction (Matthes et al., 1996; Sora et al., 1997).”
BackgroundGupta, S., Pasha, S., Gupta, Y. K., & Bhardwaj, D. (1999) · Peptides · doi:10.1016/s0196-9781(99)00028-5 · Cited by 27
Navigating the brain: the role of exosomal shuttles in precision therapeutics
Fatima, S., Qaiser, A., Andleeb, S., Hashmi, A. H., & Manzoor, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1324216 · Cited by 30
“Based on these findings, the MOR gene has been chosen as a potential drug addiction treatment target (122).”
BackgroundDoherty, T. S., & Roth, T. L. (2016) · Development and Psychopathology · doi:10.1017/s095457941600081x · Cited by 30
“This receptor is thought to be involved in both attachment and reward (Kieffer & Gavériaux-Ruff, 2002; Matthes et al., 1996; Moles, Kieffer, & D’Amato, 2004; Nelson & Panksepp, 1998), making it an interesting target considering that reward-based behaviors such as drug use may be intimately related…”
BackgroundGeneration and Characterization of Antibodies against Opioid Receptors from Zebrafish
Arévalo, J. C., Hernández-Jiménez, E., Jiménez-González, A., Torres-Valle, M., Iwasaki, R., López-Bellido, R., Vicente‐García, C., & Rodríguez, R. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010014 · Cited by 27
“Of those, MOR plays a major role in mediating the effects of opioids—analgesia and addiction [3,4]—while DOR agonists produce weak analgesic effects [5,6].”
BackgroundChefer, V. I., Kieffer, B. L., & Shippenberg, T. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.021 · Cited by 30
Self-citationMitra, S., Banerjee, T. S., Hota, S. K., Bhattacharya, D., Das, S., & Chattopadhyay, P. P. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.024 · Cited by 26
Zanos, P., Georgiou, P., Gonzalez, L. R., Hourani, S. M. O., Chen, Y., Kitchen, I., Kieffer, B. L., Winsky‐Sommerer, R., & Bailey, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw011 · Cited by 29
“While opioid drugs, including morphine and heroin, primarily act on the μ-opioid receptor (MOPr) to exert their neurochemical and behavioral effects (Matthes et al., 1996), evidence also suggests a role for the glutamatergic system to underlie several opioid addiction processes (Kalivas, 2009).”
BackgroundSelf-citationKieffer, B. L. (2016) · Nature · doi:10.1038/nature19424 · Cited by 28
Self-citationInflammation-associated changes in DOR expression and function in the mouse colon
DiCello, J. J., Saito, A., Rajasekhar, P., Eriksson, E. M., McQuade, R. M., Nowell, C. J., Sebastian, B. W., Fichna, J., Veldhuis, N. A., Canals, M., et al. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00025.2018 · Cited by 30
The effects of morphine on cell proliferation
Glasel, J. A. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8385-6_2 · Cited by 26
Zhang, R.-X., Wang, L., Liu, B., Qiao, J., Ren, K., Berman, B., & Lao, L. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.008 · Cited by 26
Opioid receptors: From genes to mice
Kieffer, B. L. (2000) · Journal of Pain · doi:10.1054/jpai.2000.9823 · Cited by 28
Self-citationDifferential desensitization of human δ-opioid receptors by peptide and alkaloid agonists
Allouche, S., Roussel, M., Marie, N., & Jauzac, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00180-6 · Cited by 26
Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices
Wu, S., Ohtubo, Y., Brailoiu, G. C., & Dun, N. J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705534 · Cited by 26
“There is a considerable interest in the pharmacology of m-opioid receptors, because the analgesia and reinforced behavior are associated principally with the activation of m-opioid receptors (Matthes et al., 1996).”
BackgroundEthological analysis of morphine withdrawal with different dependence programs in male mice
Broseta, I., Rodríguez‐Arias, M., Stinus, L., & Miñarro, J. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00277-9 · Cited by 26
“…from 3 days or even 1 day in the most rapid programs (Cappendijk et al., 1993; Ballard and McAllister, 1999; Farzin, 1999) to 5, 6, 8, or 9 days (Matthes et al., 1996; Belozertseva et al., 1996; Suzuki et al., 1997; Reddy and Kulkarni, 1997; Miranda and Pinardi, 1998) in the most frequent cases.”
BackgroundBaldo, B. A. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00314.2024 · Cited by 25
Lutz, P.-É., Pradhan, A. A. A., Goeldner, C., & Kieffer, B. L. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.02.002 · Cited by 28
“We treated mice using a morphine regimen known to induce dependence (Matthes et al., 1996) and focused on three time points (2 h, 1 and 4 weeks after the last morphine injection) to match our previous study on behavioral adaptations to chronic morphine (Goeldner et al.”
MethodSelf-citationAquino, J. P. D., Parida, S., Avila-Quintero, V. J., Flores, J. M., Compton, P. A., Hickey, T. R., Gómez, Ó., & Sofuoglu, M. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109097 · Cited by 28
Pavone, F., Luvisetto, S., Marinelli, S., Straface, E., Fabbri, A., Falzano, L., Fiorentini, C., & Malorni, W. (2009) · Pain · doi:10.1016/j.pain.2009.06.026 · Cited by 28
“To ascertain if the modulation of MORs by CNF1 could be a critical step for the observed analgesic activity, we utilized knockout mice lacking the MOR gene (l / ) [27].”
BackgroundMethodMu and Delta Opioid Receptors Diverge
Woolf, C. J. (2009) · Cell · doi:10.1016/j.cell.2009.05.033 · Cited by 26
“Once it was shown that knocking out the MOR gene completely eliminates the analgesic action of morphine, the pivotal role of this receptor in pain biology was firmly cemented (Matthes et al., 1996).”
BackgroundZaidi, S. A., Arnatt, C. K., He, H., Selley, D. E., Mosier, P. D., Kellogg, G. E., & Zhang, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.08.042 · Cited by 27
Páez-Espinosa, V., Liu, Y., Ferrini, M. G., Anghel, A., Nie, Y., Tripathi, P. V., Porche, R., Jansen, E. J., Stuart, R. C., Nillni, E. A., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.063 · Cited by 25
“Morphine, which acts primarily through the mu opioid receptors (Matthes et al., 1996), was chosen to study the effects of short-term and long-term morphine exposure on the levels of P-CREB and the prohormone convertases, PC1/3 and PC2.”
BackgroundBailey, C. P., & Husbands, S. M. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.964203 · Cited by 25
“MOPrs are expressed throughout the central nervous system, but the location where they elicit reward/euphoria is largely thought to be in the ventral tegmental area [29].”
BackgroundInfluentialBu, H., Liu, X., Tian, X., Yang, H., & Gao, F. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.896913 · Cited by 30
“Morphineinduced antinociception is mediated mainly through the activation of mu opioid receptor (MOR) [1, 2].”
BackgroundBull, F. A., Baptista‐Hon, D. T., Sneddon, C. C., Wright, L., Walwyn, W. M., & Hales, T. G. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001834 · Cited by 27
Dai, W., Liu, X.-T., Bao, Y., Yan, B., Jiang, N., Yu, B., & Liu, J. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0175-1 · Cited by 27
Salvadori, S., Trapella, C., Fiorini, S., Negri, L., Lattanzi, R., Bryant, S. D., Jinsmaa, Y., Lazarus, L. H., & Balboni, G. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.047 · Cited by 25
Purification and mass spectrometric analysis of the μ opioid receptor
Christoffers, K. H., Hong Li, A., Keenan, S. M., & Howells, R. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.08.008 · Cited by 25
Cocaine Modulates the Expression of Opioid Receptors and miR-let-7d in Zebrafish Embryos
López-Bellido, R., Barreto-Valer, K., Sánchez-Simón, F. M., & Rodríguez, R. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050885 · Cited by 26
“A consequence of this interrelationship between opioid receptors and dre-let-7d is that miRNAs can downregulate the expression of the MOR and DOR receptors that are involved in the pain process [1,2,9,66], suggesting a potential role of miRNAs in pain.”
BackgroundInfluentialWhy Does Morphine Make You Itch?
Miyamoto, T., & Patapoutian, A. (2011) · Cell · doi:10.1016/j.cell.2011.09.026 · Cited by 25
“Previous experiments had established that both MIS and MIA are mediated by m-opioid receptor (MOR) (Loh et al., 1998; Matthes et al., 1996).”
BackgroundAntihypertensive opioid-like milk peptide α-lactorphin: lack of effect on behavioural tests in mice
Ijäs, H. K., Collin, M., Finckenberg, P., Pihlanto-Leppälä, A., Korhonen, H. J. T., Korpela, R., Vapaatalo, H., & Nurminen, M. (2003) · International Dairy Journal · doi:10.1016/j.idairyj.2003.08.002 · Cited by 25
The kappa opioid receptor is associated with the perception of visceral pain
BLACK, D., & Trevethick, M. A. (1998) · Gut · doi:10.1136/gut.43.3.312 · Cited by 25
Transdermales Buprenorphin fur die Behandlung chronischer Tumor- und Nicht-Tumorschmerzen
Likar, R., Grießinger, N., Sadjak, A., & Sittl, R. (2003) · Wiener Medizinische Wochenschrift · doi:10.1046/j.1563-258x.2003.02120.x · Cited by 25
Mogil, J. S., Grisel, J. E., Hayward, M. D., Bales, J., Rubinstein, M., Belknap, J. K., & Low, M. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00422-x · Cited by 25
Klein, G. E., Juni, A., Arout, C. A., Waxman, A. R., Inturrisi, C. E., & Kest, B. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.035 · Cited by 25
“Although morphine dependence has been shown to be a consequence of activity at the μ type (Matthes et al., 1996; Berrendero et al., 2002), δ and κ receptors have amodulatory role.”
BackgroundMorphine induces short-lived changes in G-protein gene expression in rat prefrontal cortex
Kaewsuk, S., Hutamekalin, P., Ketterman, A. J., KHOTCHABHAKDI, N., Govitrapong, P., & Casalotti, S. O. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00768-8 · Cited by 25
Nevo, I., Avidor‐Reiss, T., Levy, R., Bayewitch, M. L., & Vogel, Z. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00155-0 · Cited by 25
“…is especially important, as knock-out experiments have shown that the µ receptor, but not the δ and receptors, is the molecular target of morphine in vivo, and that it is a mandatory component of the opioid system for both morphine analgesic effects and physical dependence (Matthes et al., 1996).”
Mouse μ Opioid Receptor Gene Expression
Choe, C.-Y., Im, H., KO, J. L., & Loh, H. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34926 · Cited by 24
Noble, F., & Cox, B. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37089-2 · Cited by 24
“…agonist to inhibit adenylyl cyclase activity) in the caudate putamen and the nucleus accumbens, without modification in the ability of a opioid agonist to inhibit this enzyme, may be induced by some subchronic cocaine or morphine treatment regimens (Unterwald et al., 1993; Noble and Cox, 1996).”
Potenza, M. N., Gold, S. J., Roby-Shemkovitz, A., Lerner, M. R., & Nestler, E. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35129-8 · Cited by 25
Sun, X., Zhang, Y., Lu, W., Guo, H., He, G., Luo, S., Guo, H., Zhang, Z., Wang, W., Chu, L., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c00520 · Cited by 27
Buprenorphine treatment for opioid use disorder: recent progress
Parida, S., Carroll, K. M., Petrakis, I. L., & Sofuoglu, M. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1635454 · Cited by 23
Ma, H., Obeng, S., Wang, H., Zheng, Y., Li, M., Jali, A. M., Stevens, D. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01767 · Cited by 26
Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology
Hill, R., & Canals, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107961 · Cited by 24
Metadata
- Authors
- Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B. P., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Surrey (GB)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Inserm (FR)
- Venue
- Nature
- Published
- 1996-10
- Volume
- 383
- Issue
- 6603
- Pages
- 819-823
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051746492
- Cited by
- 1,722
- References
- 25
- Citations by year
- 2026: 36 · 2025: 40 · 2024: 45 · 2023: 52 · 2022: 53 · 2021: 56 · 2020: 59 · 2019: 56 · 2018: 53 · 2017: 43 · 2016: 59 · 2015: 53 · 2014: 60 · 2013: 65 · 2012: 58
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- mu-opioid receptor, morphine, analgesia, opioid reward, place preference, opioid withdrawal, physical dependence, knockout mice, delta opioid receptor, kappa opioid receptor, opioid system, pain management
- MeSH terms
- Analgesics, Animals, Behavior, Animal, Cell Line, Enkephalins, Mice, Inbred C57BL, Morphine, Morphine Dependence, Narcotics, Reward, Substance Withdrawal Syndrome, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.